These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7841311)

  • 1. Heterogeneity of plasma tissue factor pathway inhibitor.
    Broze GJ; Lange GW; Duffin KL; MacPhail L
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):551-9. PubMed ID: 7841311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.
    Valentin S; Nordfang O; Bregengård C; Wildgoose P
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor; its structure, function and clinical significance.
    Kato H
    Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.
    Wesselschmidt R; Likert K; Huang Z; MacPhail L; Broze GJ
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):661-9. PubMed ID: 8292716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein.
    Horie S; Hiraishi S; Hamuro T; Kamikubo Y; Matsuda J
    Thromb Haemost; 2002 Jan; 87(1):80-5. PubMed ID: 11848461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
    Mukherjee M; Kakkar VV
    Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli.
    Diaz-Collier JA; Palmier MO; Kretzmer KK; Bishop BF; Combs RG; Obukowicz MG; Frazier RB; Bild GS; Joy WD; Hill SR
    Thromb Haemost; 1994 Mar; 71(3):339-46. PubMed ID: 8029799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
    Horie S; Hiraishi S; Hirata Y; Kazama M; Matsuda J
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):277-85. PubMed ID: 11085919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S; Suylen DP; Rosing J; Hackeng TM
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.
    Piro O; Broze GJ
    Circulation; 2004 Dec; 110(23):3567-72. PubMed ID: 15557366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor: proposed heparin recognition region.
    Harenberg J; Malsch R; Heene DL
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S50-6. PubMed ID: 7647222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits.
    Bregengaard C; Nordfang O; Ostergaard P; Petersen JG; Meyn G; Diness V; Svendsen O; Hedner U
    Thromb Haemost; 1993 Sep; 70(3):454-7. PubMed ID: 8259548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene.
    Chang JY; Monroe DM; Oliver JA; Roberts HR
    Thromb Haemost; 1999 Jan; 81(1):45-9. PubMed ID: 9974373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
    Wun TC; Kretzmer KK; Palmier MO; Day KC; Huang MD; Welsch DJ; Lewis C; Wolfe RA; Zobel JF; Lange GW
    Thromb Haemost; 1992 Jul; 68(1):54-9. PubMed ID: 1325078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes.
    Bajaj MS; Steer S; Kuppuswamy MN; Kisiel W; Bajaj SP
    Thromb Haemost; 1999 Dec; 82(6):1663-72. PubMed ID: 10613653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of tissue factor pathway inhibitor (TFPI) from rabbit plasma and characterization of its differences from TFPI isolated from human plasma.
    Warn-Cramer BJ; Maki SL
    Thromb Res; 1992 Aug; 67(4):367-83. PubMed ID: 1412217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.